PT  - JOURNAL ARTICLE
AU  - S M Knepper
AU  - S A Buckner
AU  - M E Brune
AU  - J F DeBernardis
AU  - M D Meyer
AU  - A A Hancock
TI  - A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype.
DP  - 1995 Jul 01
TA  - Journal of Pharmacology and Experimental Therapeutics
PG  - 97--103
VI  - 274
IP  - 1
4099  - http://jpet.aspetjournals.org/content/274/1/97.short
4100  - http://jpet.aspetjournals.org/content/274/1/97.full
SO  - J Pharmacol Exp Ther1995 Jul 01; 274
AB  - N-[5-(4,5-dihydro-1H-imidazol-2yl)-2-hydroxy-5,6,7,8-tetrahydro naphthalen-1-yl] methanesulfonamide hydrobromide (A-61603) is a novel and potent alpha-adrenoceptor agonist. In radioligand binding assays, the compound is at least 35-fold more potent at alpha 1A/a receptors than at alpha 1b or alpha 1d sites. In fibroblast cells transfected with alpha 1a receptors, A-61603 more potently stimulates phosphoinositide hydrolysis than norepinephrine, and is antagonized by prazosin. A-61603 is less potent in cells transfected with alpha 1b or alpha 1d receptors. A-61603 is a potent agonist at alpha 1A receptors in rat vas deferens (200- to 300-fold more potent than norepinephrine or phenylephrine, respectively) and in isolated canine prostate strips (130- to 165-fold more potent than norepinephrine or phenylephrine, respectively). In contrast, A-61603 is only 40-fold more potent than phenylephrine at alpha 1B sites in rat spleen and 35-fold less potent at rat aortic, alpha 1D sites. In an in vivo dog model, A-61603 raises intraurethral prostatic tone to a greater extent than mean arterial blood pressure. A-61603 induces a pressor response in conscious rats at doses 50- to 100-fold lower than phenylephrine, and the response is not attenuated by pretreatment with CEC, whereas YM-617 causes a 100-fold shift in the response. These results indicate that A-61603 is a potent adrenergic agonist, selective for alpha 1A/a receptors, and may prove a useful probe for studies of adrenergic function and alpha 1 adrenoceptor regulation of physiological functions.